Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): September 22, 2005

 


 

AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 


 

Delaware   1-16671   23-3079390

(State or Other Jurisdiction of

Incorporation or Organization)

  Commission File Number  

(I.R.S. Employer

Identification Number)

 

1300 Morris Drive Chesterbrook, PA   19087
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (610) 727-7000

 

N/A

(Former name or former address, if changed since last report.)

 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 8.01. Other Events.

 

On September 22, 2005, AmerisourceBergen Corporation (the “Registrant”) issued a news release announcing it will purchase all of its branded and generic pharmaceuticals for distribution in the U.S. only from manufacturers. In the rare instances in which a manufacturer requires the Registrant to purchase products from one or more exclusive distributors, the Registrant will adhere to the manufacturer’s requirements. A copy of the news release is filed as Exhibit 99.1 to this report and incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(c) Exhibits.

 

99.1    News Release dated September 22, 2005


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    AMERISOURCEBERGEN CORPORATION
Date: September 23, 2005   By:  

/s/ Michael D. DiCandilo


    Name:   Michael D. DiCandilo
    Title:  

Executive Vice President

and Chief Financial Officer